个性化的精度:在黑色素瘤治疗中用基于mRNA的疫苗彻底改变癌症治疗
Krishnendu Adhikary1, Abhik Paul2, Ayush Madan3
1Department of Interdisciplinary Science, Centurion University of Technology and Management, Odisha, India.
Advances in immunology
|July 30, 2025
概括
像mRNA-4157/V940这样的信使RNA (mRNA) 癌症疫苗正在成为先进的免疫疗法. 这些个性化疫苗与布罗利祖马布结合,有望促进T细胞对黑色素瘤的反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 黑色素瘤的发病率正在上升,需要新的治疗策略.
- 传统的癌症疫苗向与瘤相关的抗原,有效性有限.
- 随着COVID-19大流行的推动,信使RNA (mRNA) 技术的进步为癌症疫苗提供了新的可能性.
研究的目的:
- 审查基于mRNA的黑色素瘤癌症疫苗的临床前和临床进展.
- 突出制造挑战和解决方案在mRNA黑色素瘤疫苗的开发.
主要方法:
- 开发mRNA-4157/V940 ,一个个性化癌症疫苗编码34个患者特异性瘤新抗原.
- 结合疗法包括mRNA-4157/V940和pembrolizumab (一种PD-1抑制剂).
- 根据个体瘤突变模式量身定制的T细胞反应的评估.
主要成果:
- 早期的临床试验表明,mRNA-4157/V940和pembrolizumab的组合增强了T细胞介导的瘤杀伤.
- 疫苗指示免疫系统区分健康和恶性细胞.
- 布罗利祖马布的机制包括抑制PD-1,PD-L1和PD-L2通路.
结论:
- 个性化mRNA癌症疫苗代表了先进免疫疗法的前沿.
- 结合mRNA疫苗和检查点抑制剂 (如 pembrolizumab) 可能显著改善黑色素瘤治疗结果.
- 持续的研究和临床试验对于解决制造和疗效挑战至关重要.
相关概念视频
Cancer Vaccines
514
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
514
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K


